Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 334 of 1,261
  1. US 11040935

    Small molecule AMPK activators

    THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  2. US 11040125

    Neurotrophic factor carrier, method for producing the same, and method for regenerating a nerve using the same

    Wiregene Co., Ltd. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  3. US 11040109

    Blood coagulation protein conjugates

    Takeda Pharmaceutical Company Limited · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  4. US 11040115

    Method for the treatment of lysosomal storage diseases

    Sangamo Therapeutics, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  5. US 11040943

    Psychotropic agents and uses thereof

    LB PHARMACEUTICALS INC. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  6. US 11040088

    Delivery of therapeutic compounds to the brain and other tissues

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  7. US 11040097

    Method of conferring a protective immune response to norovirus

    Takeda Vaccines, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  8. US 11040082

    Compositions and methods for treating colorectal cancer

    United States Government as represented by the Department of Veterans Affairs · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  9. US 11040090

    Botulinum neurotoxin compositions

    Prime Bio, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  10. US 11040039

    Treatment of inflammatory disorders

    Aldeyra Therapeutics, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  11. US 11040055

    Method of treating diabetic retinopathy or wet type adult macular degeneration

    China Medical University · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  12. US 11040040

    Methods of treating cancer

    Corvus Pharmaceuticals, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  13. US 11040036

    Pyruvate kinase activators for use in treating blood disorders

    Agios Pharmaceuticals, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  14. US 11040028

    Penicinotam derivative, preparation method and use thereof

    OCEAN UNIVERSITY OF CHINA · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  15. US 11040027

    Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death

    HEPAREGENIX GMBH · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  16. US 11040073

    Compositions and methods for treating diverticulitis and related disorders

    Finch Therapeutics Holdings LLC · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  17. US 11040019

    Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  18. US 11040011

    Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same

    Pacira Pharmaceuticals, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  19. US 11040965

    Process for making Hepatitis B core protein modulators

    ASSEMBLY BIOSCIENCES, INC. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  20. US 11040970

    VMAT2 inhibitor compounds and compositions thereof

    Neurocrine Biosciences, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  21. CN 112996764

    CHELATING AAZTA CONJUGATES AND COMPLEXES THEREOF

    BRACCO IMAGING SPA · Granted Jun 18, 2021 · Expires Jun 13, 2041

    granted
  22. US 11034957

    Amyloid precursor protein (APP) RNAi agent compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  23. US 11033626

    Progesterone formulations having a desirable pk profile

    Compass Therapeutics LLC · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  24. US 11035859

    Compositions and methods for detecting protease activity in biological systems

    CytomX Therapeutics, Inc. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.